The incidence of pediatric allergic diseases is rising. In addition, diseases such as allergic rhinitis, asthma, food allergy, and anaphylaxis are occurring at an earlier age than previously observed. The key to the control of atopic diseases in children less than seven years of age lies in understanding the events that lead to the development of allergy. Therapeutic agents in these young children are needed to both control and eliminate these disease states.

We invite authors to submit original research, case reports, and review articles that are designed to advance our understanding of allergy in young children. In particular, we are interested in articles describing the relation of early onset allergy to the development of atopic diseases such as asthma, allergic rhinitis, food allergy, and eosinophilic esophagitis. Articles describing therapeutic agents and new markers to both identify and define whether the control of these atopic diseases has been attained are also of high interest. Potential topics include, but are not limited to:

• New findings in the epidemiology and the evolution of pediatric asthma
• Impact of development of pediatric allergies on both rhinitis and asthma
• New biomarkers including clinical markers that identify the current disease state in asthma; implications for altering treatment course
• Onset and immunologic events leading to the development of pediatric allergic rhinitis
• Identification of immunologic factors leading to the development of food allergy in young children
• Early events in eczema: is it skin barrier defects or allergy?
• Genetic influences on the development of pediatric allergy, asthma, and eczema
• Microbiota and prevention of allergic responses in infants and children
• New therapies in pediatric allergic rhinitis and asthma
• New therapies in food allergy/anaphylaxis and eosinophilic esophagitis